期刊文献+

白大衣高血压患者的血小板功能

Analysis of platelet function in patients with white coat hypertension
原文传递
导出
摘要 目的:探讨白大衣高血压(WCH)患者的血小板功能。方法:选初诊的原发性高血压(EH)患者、WCH患者、正常血压(NT)者各35例,通过诊室血压测量和24h动态血压监测,同时测定并比较3组血小板最大聚集率(PAGTmax)、血浆血小板α-颗粒膜蛋白(GMP-140)含量、平均血小板容积(MPV)、血小板数量的变化。结果:和NT对照组相比,EH组和WCH组PAGTmax、血浆血小板GMP-140含量、MPV均明显增加(P<0.05)而三组血小板计数无统计学差异,同时EH组的PAGTmax、血浆血小板GMP-140含量、MPV均高于WCH组(P<0.05)。EH组和WCH组MPV与24h平均舒张压、GMP-140含量均正相关(P<0.05)。结论:WCH存在血小板活化,可能和心血管事件发生率增加有关。 Objective: To investigate the change of platelet function in patients with essential hypertension (EH), white coat hypertension (WCH)and normotension (NT). Method:Participants were classified as EH (n= 40), WCH (n= 40), or NT (n: 40) on the basis of clinic and 24 hour ambulatory blood pressure monitoring. The change of maximum platelet aggregation rate(PAGTmax), the level of platelet alpha-granule membrane pro- tein(GMP-140)and the mean platelet volume (MPV)were measured between the subjects. Result: Compared with NT controls, the PAGTmax, the level of GMP-140 and the MPV were significantly higher in patients with EH and WCH (P〈0.05), those were also higher in essential hypertensives than in white coat hypertensives(P〈 0.05). MPV was positively correlated with the level of GMP-140 and the 24 hour ambulatory diastolic blood pres- sure in EH group as well as in WCH group. Conclusion: There exist enhanced platelet activity in WCH by which white coat hypertensive may be at increased cardiovascular risk.
作者 原芳 王丽霞
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第10期733-735,共3页 Journal of Clinical Cardiology
关键词 高血压 血小板活化 血小板功能试验 white coat hypertension hypertension platelet activity
  • 相关文献

参考文献17

  • 1MANCIA G, DE BACKER G, DOMINICZAK A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension[J]. J Hypertens,2007,25 : 1751--1762.
  • 2VERDECCHIA P, ANGELI F, GATTOBIGIO R,et al. The clinical significance of white-coat and masked hypertension[J]. Blood Press Monit, 2007,12 : 387- 389.
  • 3STRANDBERG T E, SALOMAA V. White coat effect,blood pressure and mortality in men. prospective cohort study[J]. Eur Heart J,2000,21:1714- 1718.
  • 4SMITH P A. GRAHAM L N,MACKINTOSH A F, et al. Sympathetic neural mechanisms in white-coate hypertension[J]. J AM Coll Cardiol, 2002,40 : 126-- 132.
  • 5CARDILLO C,DEFELICE F, CAMPIA U, et al. Psychophysiological reactivity and cardiac end organ changes in whit coat hypertension [J]. Hypertension, 1993,21 : 836 -- 844.
  • 6MULDOON M F, NAZZARO P, SUTTON-TYRRELL K, et al. White coat hypertension and carotid artery atherosclerosis : A matching study[J]. Arch Intern Med, 2000,160 : 15()7-- 1512.
  • 7MAKRIS T, STAVROULAKIS G, PAPADOPOU- LOS D, et al. White coat hypertension and haemostatic/fibrinolytic balance disorders [J]. Eur Cytokine Netw,2006 ,17:137--141.
  • 8BJORKLUND K, LIND L,VESSBY B,et al. Different metabolic predictors of white coat and sustained hypertension over20year follow up period: a population based study of elderly men [J]. Circulation , 2002,106..63--68.
  • 9GoMEZ-CEREZO J, RIOS BLANCO J J, SUAREZ GARCIA I, et al. Noninvasive study of endothelial function in white coat hypertension [J]. Hypertension, 2002 ,40:304--309.
  • 10PIERDOMENICO S D, CIPOLLONE F, LAPENNA D,et al. Endothelial function in sustained and white coat hypertension[J]. Am J Hypertens, 2002 , 15 : 946--952.

二级参考文献16

  • 1ROBERT S, TRICINO G, LANZAROTCI A, et al, Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population [J]. Circultion, 2001, 104 : 1385 - 1392.
  • 2McKAY D W, MYERS M G, t3OLLI P. A Chockalingam. Masked hypertension: A common but insidious presentation of hypertension[J]. Can J Cardiol, 2006,22:617-620.
  • 3SEGA R, TROCINO G, LANZAROTTI A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study ) [J]. Circulation, 2001,104 : 1385-1392.
  • 4BOBRIE G, CHATELLIER G, GENES N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients[J]. JAMA, 2004,291 : 1342-1349.
  • 5GRASSI G, TURRI C, VAILATI S, et al. Muscle and skin sympathetic nerve traffic during the "whitecoat effect"[J]. Circulation, 1999,100 : 222- 225.
  • 6WING L M, BROWN M A, BEIIAN L J, et al. "Reverse white-coat hypertension" in older hypertension [J]. J Hypertens, 2002,20 : 639-644.
  • 7MANCIA G, SEGA R, BRAVI C, et al. Ambulatory blood pressure normality: results from the PAMELA study[J]. J Hypertens, 1995,13 : 1377-1390.
  • 8OHKUBO T, KIKUYA M, METOKI H, et al. Prognosis of "masked hypertension" and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study[J]. J Am Coll Cardiol, 2005,46: L508-515.
  • 9LIU J E, ROMAN M J, PINI R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure [J]. Ann Inter Med, 1999,131:564-572.
  • 10PICKERING T G, HALL J E, APPEL L J, et al. Recommendations for blood pressure measurement in humans and experimental animals part 1: blood pressure measurement in humans[J]. Circulation, 2005, 111:697-716.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部